共 95 条
- [1] Dolgin E(2016)Early clinical data raise the bar for hemophilia gene therapies Nat Biotechnol 34 999-1001
- [2] Manno CS(2006)Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response Nat Med 12 342-347
- [3] Pierce GF(2014)Long-term safety and efficacy of factor IX gene therapy in hemophilia B N Engl J Med 371 1994-2004
- [4] Arruda VR(2016)Phase I open label liver-directed gene therapy clinical trial for acute intermittent porphyria J Hepatol 65 776-783
- [5] Glader B(2013)Safety and liver transduction efficacy of rAAV5-cohPBGD in nonhuman primates: a potential therapy for acute intermittent porphyria Hum Gene Ther 24 1007-1017
- [6] Ragni M(2013)Adeno-associated viral vector serotype 5 poorly transduces liver in rat models PLoS One 8 e82597-1887
- [7] Rasko JJ(2015)Comparative study of liver gene transfer with AAV vectors based on natural and engineered AAV capsids Mol Ther 23 1877-250
- [8] Nathwani AC(2011)Sustained enzymatic correction by rAAV-mediated liver gene therapy protects against induced motor neuropathy in acute porphyria mice Mol Ther 19 243-1421
- [9] Reiss UM(2007)Safe and efficient transduction of the liver after peripheral vein infusion of self-complementary AAV vector results in stable therapeutic expression of human FIX in nonhuman primates Blood 109 1414-1960
- [10] Tuddenham EG(2011)Stable human FIX expression after 0.9G intrauterine gene transfer of self-complementary adeno-associated viral vector 5 and 8 in macaques Mol Ther 19 1950-1049